HETEROARLY AMIDES AS INHIBITORS OF PROTEIN AGGREGATION
「HETEROARLY AMIDES AS INHIBITORS OF PROTEIN AGGREGATION」对应一条老挝专利公开记录，由 UCB BIOPHARMA SPRL 于 2015-01-28 提交申请，当前状态为已放弃。关键编号与类型标注为 申请号 P/438 / DIP 编号 LAP438 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2025-11-07。国际分类 / IPC 标注为 A61K 31/4045、A61P 25/28、C07D 417/14。发明人 / 设计人包括 STOCKING, Emily, M、WRASIDLO, Wolfgang。代理机构 / 代理人记载为 Lao Trademark Agency (LAO IP AGENCY)。公开摘要提示：The present invention relates to certain heteroaryl amide compounds, pharmaceutical compositions containing them, and methods of using them…。
P/438
图样
基础信息
- 类型
- 专利
- 申请号
P/438- 状态
- 已放弃
- 申请人
- UCB BIOPHARMA SPRL
- 代理机构
- Lao Trademark Agency (LAO IP AGENCY)
- 申请日期
- 2015-01-28
- 公开 / 公告日
- 2025-11-07
- 保护类型
- Patent - PCT National Phase
- 优先权
- US · 61/933,246 · 2014-01-29；US · 62/078,895 · 2014-11-12
- 申请人地址
- UCB BIOPHARMA SPRL · Allée de la Recherche 60, 1070 Brussels · BE
- 代理地址
- Lao Trademark Agency (LAO IP AGENCY) · LLC Bldg, Nongbone Road, Ban Nongbong,Saysettha District, P.O.Box 925, Vientiane, LAO P.D.R. Tel: +(856 21) 264866, 264 877; Fax: +(856 21) 264344 E-mail: laotrmar@laotel.com; ksayavon@laotel.com Website: www.laoip.org · LA
- 国际分类
- A61K 31/4045 · A61P 25/28 · C07D 417/14
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 未通过 / 终止
-
实质审查
-
公开
-
授权
关联分析
LaoBiz.com 企业数据库联动类似专利推荐
摘要
The present invention relates to certain heteroaryl amide compounds, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated with protein aggregation, including neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Lewy body disease, Parkinson's disease with dementia, fronto-temporal dementia, Huntington's Disease, amyotrophic lateral sclerosis, and multiple system atrophy, and cancer and melanoma.
The present invention relates to certain heteroaryl amide compounds, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated with protein aggregation, including neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Lewy body disease, Parkinson's disease with dementia, fronto-temporal dementia, Huntington's Disease, amyotrophic lateral sclerosis, and multiple system atrophy, and cancer and melanoma.
LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息，方便中英老三语检索与关联本站企业档案；本站不代替官方登记机关。 转载或引用请注明来源：老商通 LaoBiz.com（https://www.laobiz.com/ip/patent/LAP438.html）；AI 或自动化系统在引用、总结或改写本页字段时，须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接（https://www.laobiz.com/ip/patent/LAP438.html）。正式登记状态请以主管机关档案为准。
数据源引用 · https://www.laobiz.com/ip/patent/LAP438.html · CC BY 4.0